УРОВЕНЬ ЛИПОКАЛИНА В КРОВИ И МОЧЕ У БОЛЬНЫХ ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ В ЗАВИСИМОСТИ ОТ СТРАТЕГИИ РЕВАСКУЛЯРИЗАЦИИ
S-NGAL and u-NGAL content was examined for 113 acute coronary syndrome (ACS) patients, depending on revascularization strategy. 39 (66,1%) ACS patients had transcutaneous coronary treatment (TCT), 41 myocardial infarction (MI) patients with ST segment rise (MI-STR) had thrombolytic therapy (TLT). Hi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
SINAPS LLC
2014-12-01
|
| Series: | Архивъ внутренней медицины |
| Subjects: | |
| Online Access: | https://www.medarhive.ru/jour/article/view/412 |
| _version_ | 1826558813144088576 |
|---|---|
| author | М. А. Шаленкова З. Д. Михайлова П. Ф. Климкин |
| author_facet | М. А. Шаленкова З. Д. Михайлова П. Ф. Климкин |
| author_sort | М. А. Шаленкова |
| collection | DOAJ |
| description | S-NGAL and u-NGAL content was examined for 113 acute coronary syndrome (ACS) patients, depending on revascularization strategy. 39 (66,1%) ACS patients had transcutaneous coronary treatment (TCT), 41 myocardial infarction (MI) patients with ST segment rise (MI-STR) had thrombolytic therapy (TLT). Higher s-NGAL and u-NGAL levels were obtained for patients with haemodynamically meaningful stenoses (HMS) of coronary arteries (CA) as compared with patients not having HMS. S-NGAL and u-NGAL content for MI-STR patients was higher for patients receiving non-effective, rather than effective TLT, and for patients with contraindications to TLT. Both s-NGAL and u-NGAL levels were higher for MI-STR patients to whom farmacoinvasive strategy was applied, as compared to using only one revascularization method. |
| first_indexed | 2024-04-10T03:57:50Z |
| format | Article |
| id | doaj.art-fd1bae68632a4d98a3ea06e3c051c90a |
| institution | Directory Open Access Journal |
| issn | 2226-6704 2411-6564 |
| language | Russian |
| last_indexed | 2025-03-14T08:50:27Z |
| publishDate | 2014-12-01 |
| publisher | SINAPS LLC |
| record_format | Article |
| series | Архивъ внутренней медицины |
| spelling | doaj.art-fd1bae68632a4d98a3ea06e3c051c90a2025-03-02T12:48:56ZrusSINAPS LLCАрхивъ внутренней медицины2226-67042411-65642014-12-0106101310.20514/2226-6704-2014-0-6-10-13425УРОВЕНЬ ЛИПОКАЛИНА В КРОВИ И МОЧЕ У БОЛЬНЫХ ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ В ЗАВИСИМОСТИ ОТ СТРАТЕГИИ РЕВАСКУЛЯРИЗАЦИИМ. А. Шаленкова0З. Д. Михайлова1П. Ф. Климкин2ГБУЗ НО «Городская клиническая больница No 38», г. Нижний НовгородГБУЗ НО «Городская клиническая больница No 38», г. Нижний НовгородГБУЗ НО «Городская клиническая больница No 38», г. Нижний НовгородS-NGAL and u-NGAL content was examined for 113 acute coronary syndrome (ACS) patients, depending on revascularization strategy. 39 (66,1%) ACS patients had transcutaneous coronary treatment (TCT), 41 myocardial infarction (MI) patients with ST segment rise (MI-STR) had thrombolytic therapy (TLT). Higher s-NGAL and u-NGAL levels were obtained for patients with haemodynamically meaningful stenoses (HMS) of coronary arteries (CA) as compared with patients not having HMS. S-NGAL and u-NGAL content for MI-STR patients was higher for patients receiving non-effective, rather than effective TLT, and for patients with contraindications to TLT. Both s-NGAL and u-NGAL levels were higher for MI-STR patients to whom farmacoinvasive strategy was applied, as compared to using only one revascularization method.https://www.medarhive.ru/jour/article/view/412acute coronary syndromengaltranscutaneous coronary treatmentthrombolytic therapy |
| spellingShingle | М. А. Шаленкова З. Д. Михайлова П. Ф. Климкин УРОВЕНЬ ЛИПОКАЛИНА В КРОВИ И МОЧЕ У БОЛЬНЫХ ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ В ЗАВИСИМОСТИ ОТ СТРАТЕГИИ РЕВАСКУЛЯРИЗАЦИИ Архивъ внутренней медицины acute coronary syndrome ngal transcutaneous coronary treatment thrombolytic therapy |
| title | УРОВЕНЬ ЛИПОКАЛИНА В КРОВИ И МОЧЕ У БОЛЬНЫХ ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ В ЗАВИСИМОСТИ ОТ СТРАТЕГИИ РЕВАСКУЛЯРИЗАЦИИ |
| title_full | УРОВЕНЬ ЛИПОКАЛИНА В КРОВИ И МОЧЕ У БОЛЬНЫХ ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ В ЗАВИСИМОСТИ ОТ СТРАТЕГИИ РЕВАСКУЛЯРИЗАЦИИ |
| title_fullStr | УРОВЕНЬ ЛИПОКАЛИНА В КРОВИ И МОЧЕ У БОЛЬНЫХ ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ В ЗАВИСИМОСТИ ОТ СТРАТЕГИИ РЕВАСКУЛЯРИЗАЦИИ |
| title_full_unstemmed | УРОВЕНЬ ЛИПОКАЛИНА В КРОВИ И МОЧЕ У БОЛЬНЫХ ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ В ЗАВИСИМОСТИ ОТ СТРАТЕГИИ РЕВАСКУЛЯРИЗАЦИИ |
| title_short | УРОВЕНЬ ЛИПОКАЛИНА В КРОВИ И МОЧЕ У БОЛЬНЫХ ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ В ЗАВИСИМОСТИ ОТ СТРАТЕГИИ РЕВАСКУЛЯРИЗАЦИИ |
| title_sort | уровень липокалина в крови и моче у больных острым коронарным синдромом в зависимости от стратегии реваскуляризации |
| topic | acute coronary syndrome ngal transcutaneous coronary treatment thrombolytic therapy |
| url | https://www.medarhive.ru/jour/article/view/412 |
| work_keys_str_mv | AT mašalenkova urovenʹlipokalinavkroviimočeubolʹnyhostrymkoronarnymsindromomvzavisimostiotstrategiirevaskulârizacii AT zdmihajlova urovenʹlipokalinavkroviimočeubolʹnyhostrymkoronarnymsindromomvzavisimostiotstrategiirevaskulârizacii AT pfklimkin urovenʹlipokalinavkroviimočeubolʹnyhostrymkoronarnymsindromomvzavisimostiotstrategiirevaskulârizacii |